JESSICA P HWANG to Prevalence
This is a "connection" page, showing publications JESSICA P HWANG has written about Prevalence.
Connection Strength
0.355
-
Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study. Support Care Cancer. 2021 Jan; 29(1):97-105.
Score: 0.100
-
HIV Testing in Patients With Cancer at the Initiation of Therapy at a Large US Comprehensive Cancer Center. J Oncol Pract. 2015 Sep; 11(5):384-90.
Score: 0.072
-
Hepatitis C virus screening in patients with cancer receiving chemotherapy. J Oncol Pract. 2014 May; 10(3):e167-74.
Score: 0.065
-
Association of lifestyle behaviors with non-alcoholic fatty liver disease and advanced fibrosis detected by transient elastography among Hispanic/Latinos adults in the U.S. Ethn Health. 2023 02; 28(2):299-312.
Score: 0.028
-
Improving the Prevalence of HIV Testing Among Patients in a Gynecologic Oncology Department: Results of a Quality Improvement Project. JCO Oncol Pract. 2020 01; 16(1):e109-e116.
Score: 0.024
-
Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices. JAMA Oncol. 2019 Apr 01; 5(4):497-505.
Score: 0.023
-
Prevalence and outcomes of non-alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States. Liver Int. 2019 04; 39(4):748-757.
Score: 0.023
-
Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients. Future Oncol. 2016 May; 12(10):1219-31.
Score: 0.019